-
+++ NEWS +++
PreviPharma Announces Strategic Partnership with Global Biotherapeutics Leader CSL Behring
November 11th, 2020 | PreviPharma today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop novel plasma protein-based medicines.
-
+++ NEWS +++
Cope with covid stories: PreviPharma
April 21st, 2020 | Scientists from all around the world are working intensely on innovative treatments for the lung disease Covid-19. Mannheim is a centre of German medical technology and the company PreviPharma is working on very promising approaches in the foundation and competence centre CUBEX41. […]
-
+++ NEWS +++
PreviPharma and Institute for Medical Microbiology and Hygiene, University Medicine Mannheim collaborate to share common platform to address Antimicrobial Resistance (AMR)
April 7th, 2020 | PreviPharma and Institute for Medical Microbiology and Hygiene, University Medicine Mannheim (UMM) will collaborate using PreviPharma’s Medical Innovation Platform (MIP) approach to combat Antimicrobial Resistance (AMR), a severe, life-threatening condition with unmet medical need.
-
+++ JOBS +++
PreviPharma is looking for talented intellectuals to complete our team in the future. At the moment we do not have any vacancies.
-
Our Vision
Through PreviPharma‘s services and innovations, we will …
… become the premier medical innovation platform for the plasma industry.
… be involved in the development of at least 5 new plasma protein products or indications.
… improve 100 Million patient lifes.
… employ and develop the brightest talent.
-
What is the meaning of PreviPharma?
latin: praevidere | english: to foresee
… because we “foresee” our Customers needs and anticipate Industry Trends to come up with the high value solutions for current problems…
PreviPharma – Innovative Services for the Plasma Industry
PreviPharma News
PreviPharma Announces Strategic Partnership with Global Biotherapeutics Leader CSL Behring
November 11th, 2020
PreviPharma today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop novel plasma protein-based medicines.
Cope with covid stories: PreviPharma
April 21st, 2020
Scientists from all around the world are working intensely on innovative treatments for the lung disease Covid-19. Mannheim is a centre of German medical technology and the company PreviPharma is working on very promising approaches in the foundation and competence centre CUBEX41. […]
Marc Mazur, CEO of PreviPharma:„ In order to save lives and relieve the burden on the healthcare system, we and our partners want to offer solutions for patients in urgent need as quickly as possible.“